Dashboard
Manage Tickers

HALO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Halozyme Therapeutics Announces Johnson & ...
11/07/2025 13:31:58

Halozyme Therapeutics, Inc. (NASDAQ:HALO) (Halozyme) today announced that Johnson & Johnson received U.S. Food and Drug Adm...

reported-earlier-halozyme-therapeutics-prices-private-offering-of-650m-0-convertible-senior-notes-due-2031-and-650m-0875-convertible-senior-notes-due-2032
Reported Earlier, Halozyme Therapeutics Pr...
11/07/2025 08:02:02

halozyme-therapeutics-announces-proposed-650m-convertible-senior-notes-due-2031-and-650m-notes-due-2032-offering
Halozyme Therapeutics Announces Proposed $...
11/05/2025 21:50:10

halozyme-therapeutics-raises-fy2025-adj-eps-guidance-from-600-640-to-610-650-vs-616-est-raises-fy2025-sales-guidance-from-1275b-1355b-to-1300b-1375b-vs-1319b-est
Halozyme Therapeutics Raises FY2025 Adj EP...
11/03/2025 21:03:19

halozyme-therapeutics-q3-adj-eps-172-beats-163-estimate-sales-354264m-beat-339922m-estimate
Halozyme Therapeutics Q3 Adj. EPS $1.72 Be...
11/03/2025 21:02:27

earnings-scheduled-for-november-3-2025
Earnings Scheduled For November 3, 2025
11/03/2025 11:11:31

insights-into-halozyme-therapeuticss-upcoming-earnings
Insights into Halozyme Therapeutics's Upco...
10/31/2025 18:02:23

jp-morgan-maintains-neutral-on-halozyme-therapeutics-raises-price-target-to-65
JP Morgan Maintains Neutral on Halozyme Th...
10/27/2025 14:19:59

JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:HALO) with a Neutral and raises the price target from ...

morgan-stanley-maintains-overweight-on-halozyme-therapeutics-lowers-price-target-to-79
Morgan Stanley Maintains Overweight on Hal...
10/20/2025 15:35:18

Morgan Stanley analyst Vikram Purohit maintains Halozyme Therapeutics (NASDAQ:HALO) with a Overweight and lowers the price t...

the-analyst-verdict-halozyme-therapeutics-in-the-eyes-of-10-experts
The Analyst Verdict: Halozyme Therapeutics...
10/15/2025 20:01:22

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-90-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
10/15/2025 10:31:43

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $...

leerink-partners-upgrades-halozyme-therapeutics-to-market-perform-announces-70-price-target
Leerink Partners Upgrades Halozyme Therape...
10/14/2025 18:22:24

Leerink Partners analyst David Risinger upgrades Halozyme Therapeutics (NASDAQ:HALO) from Underperform to Market Perform and...

hc-wainwright--co-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-90
HC Wainwright & Co. Maintains Buy on Haloz...
10/02/2025 10:33:51

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the p...

halozyme-to-acquire-elektrofi-in-deal-comprising-of-750m-upfront-payment-and-up-to-three-50m-milestone-payments-contingent-on-three-separate-product-regulatory-approvals-royalty-revenue-contribution-expected-as-early-as-2030
Halozyme To Acquire Elektrofi In Deal Comp...
10/01/2025 11:05:20

benchmark-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-90
Benchmark Maintains Buy on Halozyme Therap...
09/24/2025 12:24:30

Benchmark analyst Robert Wasserman maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the price target from...

forecasting-the-future-7-analyst-projections-for-halozyme-therapeutics
Forecasting The Future: 7 Analyst Projecti...
09/22/2025 12:02:57

hc-wainwright--co-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-85
HC Wainwright & Co. Maintains Buy on Haloz...
09/22/2025 10:36:37

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the p...

what-7-analyst-ratings-have-to-say-about-halozyme-therapeutics
What 7 Analyst Ratings Have To Say About H...
08/18/2025 20:01:43

morgan-stanley-maintains-overweight-on-halozyme-therapeutics-raises-price-target-to-80
Morgan Stanley Maintains Overweight on Hal...
08/18/2025 12:52:31

Morgan Stanley analyst Vikram Purohit maintains Halozyme Therapeutics (NASDAQ:HALO) with a Overweight and raises the price t...

jp-morgan-maintains-neutral-on-halozyme-therapeutics-raises-price-target-to-63
JP Morgan Maintains Neutral on Halozyme Th...
08/07/2025 19:17:29

JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:HALO) with a Neutral and raises the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION